Infrastructure
Our Businesses
For us, building and maintaining a healthy work culture is crucial – we are defined by our values and it is through them that we are able to consistently evolve.
From Annual Reports and Balance Sheets to Shareholding Patterns – everything investors need to know.
With a reliable supply chain and cost competitiveness in the dynamic market, Ipca has emerged as one of India’s top API exporters.
Our Corporate Social Responsibility involves initiatives on a micro level to include patient health, employee and public safety, nurturing of the environment and building sustainable communities.
Come and find out more about us
and the exciting career
opportunities available at Ipca.
Queries about our products or services?
Connect with us:
Ipca to market NovaLead’s patented, repurposed drug Diulcus® for the treatment of Diabetic Foot Ulcer (DFU)
The approval is based on Phase III study which established that NovaLead’s patented drug branded as Diulcus®, which will be marketed in India by Ipca. Diulcus® promotes the complete closure of DFU significantly better than Standard of Care, which is the present treatment of choice. Currently there is a global unmet medical need for the treatment of DFU.
Leave us your details so we can get in touch with you.
Fields marked by * are compulsory.